Table 3.
Fgf23 mRNA levels
|
iFGF23 Plasma | ||||||||
---|---|---|---|---|---|---|---|---|---|
Bone | Bone marrow | Thymus | Spleen | Kidney | Intestine | Lung | Liver | ||
IL-1β | + | + | + | + | + | + | + | + | + |
Tnfα | + | + | + | + | + | + | + | − | + |
LPS | + | + | + | + | − | + | + | + | + |
Oxalate diet | + | UD | + | × | + | UD | UD | × | + |
A comparison of the results of Fgf23 mRNA regulation by inflammatory cytokines and CKD in different tissues with levels in the circulation as observed in Figs. 3–7.
+ = −16kb enhancer plays a role in the Fgf23 induction; − = −16kb enhancer does not play a role in Fgf23 induction; X = Fgf23 is not regulated; UD = −Fgf23 levels were not measured.